نتایج جستجو برای: cytogenetic risk groups

تعداد نتایج: 1591243  

پایان نامه :0 1392

it is definitely necessary to understand the concept and behavior of causation of life insurance policies and its determinants for insurance managers, regulators, and customers. for insurance managers, the profitability and liquidity of insurers can be increasingly influenced by the number of causation through costs, adverse selection, and cash surrender values. therefore, causation is a materi...

Journal: :Experimental oncology 2013
E A Diomina V F Chekhun

AIM On the basis of the cytogenetic research, to develop and validate the strategy of the measures to prevent the stochastic effects of low-doses radiation on humans. METHODS Test system with human peripheral blood lymphocytes, metaphase analysis of chromosomal aberrations was used. Cells were cultured according to the standard procedures with modifications. The analysis of painted chromosome...

2012
Elias Bou Samra Bernard Klein Thérèse Commes Jérôme Moreaux

Patients with normal karyotype represent the single largest cytogenetic group of acute myeloid leukemia (AML), with highly heterogeneous clinical and molecular characteristics. In this study, we sought to determine new prognostic biomarkers in cytogenetically normal (CN)-AML patients. A gene expression (GE)-based risk score was built, summing up the prognostic value of 22 genes whose expression...

Journal: :international journal of molecular and cellular medicine 0
farhad zaker cellular and molecular research center, iran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences) naser amirizadeh blood transfusion research center, high institute for education and research in transfusion medicine, tehran, iran.سازمان اصلی تایید شده: سازمان انتقال خون ایران (blood transfusion research center) nahid nasiri department of hematology, school of allied medicine, iran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences) seyed mohsen razavi hematology and oncology department, firoozgar hospital, iran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی ایران (iran university of medical sciences) ladan teimoori-toolabi molecular medicine department, biotechnology research center, pasteur institute of iran, tehran, iran.سازمان اصلی تایید شده: انستیتو پاستور ایران (pasteur institute of iran) marjan yaghmaie hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی تهران (tehran university of medical sciences)

myelodysplastic syndromes (mdss) are a clonal bone marrow (bm) disease characterized by ineffective hematopoiesis, dysplastic maturation and progression to acute myeloid leukemia (aml). methylation silencing of hrk has been found in several human malignancies. in this study, we explored the association of hrk methylation status with its expression, clinical parameters and mds subtypes in mds pa...

Myelodysplastic syndromes (MDSs) are a clonal bone marrow (BM) disease characterized by ineffective hematopoiesis, dysplastic maturation and progression to acute myeloid leukemia (AML). Methylation silencing of HRK has been found in several human malignancies. In this study, we explored the association of HRK methylation status with its expression, clinical parameters and MDS subtypes in MDS pa...

Journal: :Blood 1998
T J Nevill H C Fung J D Shepherd D E Horsman S H Nantel H G Klingemann D L Forrest C L Toze H J Sutherland D E Hogge S C Naiman A Le D A Brockington M J Barnett

Allogeneic bone marrow transplantation (BMT) is the only curative therapy available for patients with myelodysplastic syndrome (MDS). In an attempt to identify prognostic factors influencing outcome, we collected data retrospectively on 60 consecutive adult patients who had undergone BMT at our center for primary MDS or acute myelogenous leukemia evolving from preexisting primary MDS (sAML). Pa...

Journal: :Haematologica 2009
Jamshid Sorouri Khorashad Simon Wagner Liat Greener David Marin Alistair Reid Dragana Milojkovic Hetal Patel Shaun Willimott Katy Rezvani Gareth Gerrard Sandra Loaiza John Davis John Goldman Junia Melo Jane Apperley Letizia Foroni

Imatinib is currently the first line therapy for newly diagnosed patients with chronic myeloid leukemia. However, 20-25% of patients do not achieve durable complete cytogenetic responses. The mechanism underlying this primary resistance is unknown, but variations in BCR-ABL1 kinase activity may play a role and can be investigated by measuring the autophosphorylation levels of BCR-ABL1 or of a s...

Journal: :Blood 2016
Pieter Sonneveld Hervé Avet-Loiseau Sagar Lonial Saad Usmani David Siegel Kenneth C Anderson Wee-Joo Chng Philippe Moreau Michel Attal Robert A Kyle Jo Caers Jens Hillengass Jesús San Miguel Niels W C J van de Donk Hermann Einsele Joan Bladé Brian G M Durie Hartmut Goldschmidt María-Victoria Mateos Antonio Palumbo Robert Orlowski

The International Myeloma Working Group consensus updates the definition for high-risk (HR) multiple myeloma based on cytogenetics Several cytogenetic abnormalities such as t(4;14), del(17/17p), t(14;16), t(14;20), nonhyperdiploidy, and gain(1q) were identified that confer poor prognosis. The prognosis of patients showing these abnormalities may vary with the choice of therapy. Treatment strate...

Journal: :Annales de genetique 2001
H Chaabouni M Chaabouni F Maazoul R M'Rad L B Jemaa N Smaoui K Terras H Kammoun N Belghith H Ridene B Oueslati F Zouari

Cytogenetic prenatal diagnosis (PND) is under national health program in most developed countries, while it concerns a small part of population at risk in developing countries. Finance is common reason of absence of PND development, but socio-cultural believes play an important role in Arab Muslim countries. In this paper we report results of 3110 fetal karyotypes carried out in a Tunisian popu...

Journal: :International journal of hematology 2011
Bin-Tao Huang Yu Wang Qing-Feng Du Jun Yang Jessica Yu Qing-Chun Zeng Na Xu Jin-Fang Zhang Lu-Lu Xu Xu-Jing Luo Yong-Qiang Wei Xiao-Li Liu

High-dose arabinoside (HiDAC) and daunorubicin (DNR)-based chemotherapy are the primary consolidation treatment options for older adults (50-60 years old) with acute myeloid leukemia in China. We analyzed the event-free survival (EFS) and hospital treatment charges of older adult patients with different cytogenetic risk profiles. In patients with a better/intermediate risk profile, the average ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید